Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Asheville, NC Metro Edition
Focus: LIFE SCI
Asheville's talent gap splits: clinical pay climbs, lab pay slides.
3.6%-3.8%
Asheville metro unemployment
vs 4.1% national, 3.5% NC statewide
~3% below pre-storm level
Post-Helene employment gap
As of Dec 2025, still unresolved
$78,011
CRA advertised pay (metro)
vs $90,956 national median, trending up
$3B+ combined (Amgen, J&J)
NC biopharma mega-investment
790 new jobs across two Triangle sites
This Month's Takeaways
CRA pay is accelerating while lab tech pay is falling — in the same metro.
Metro CRA advertised pay rose to $78,011 even as Lab Technician pay dropped to $49,383, a divergence consistent with national patterns separating regulatory/clinical specialists from commodity lab roles. Compensation strategy built on a single 'life sci' pay band risks under-pricing clinical talent and over-paying for roles facing softening demand.
Triangle expansion is quietly raising Asheville's competitive bar.
J&J's $2B Wilson County campus and Amgen's Holly Springs expansion are adding thousands of biomanufacturing and quality jobs within driving distance of experienced NC talent pools. Asheville-area employers may need to benchmark against Triangle pay scales, not just regional averages, to retain quality and regulatory staff tempted by nearby mega-projects.
Post-Helene labor supply gap hasn't closed — and that's a retention lever.
Metro employment remains roughly 3% below pre-hurricane levels, meaning the broader talent pool life sci employers draw from for lab support, facilities, and operations staff is still constrained. Current conditions suggest retention investment may outperform open-market recruiting for hard-to-backfill operational roles in the near term.
Selective biopharma hiring continues despite national layoff headlines.
64% of surveyed biopharma organizations report active recruiting even as September saw layoffs at BioMarin and Bristol Myers Squibb, confirming cuts are concentrated in consolidation rather than execution-critical functions. This pattern may create openings to recruit experienced regulatory and CMC talent shed from larger organizations without matching their pay inflation.
Local Labor Conditions
Asheville's unemployment rate held near 3.6%-3.8% through the latest data, outperforming the national 4.1% rate even as the metro's employment base remains roughly 3% below pre-Hurricane Helene levels, a recovery gap that continues to constrain available skilled labor supply. Statewide biomanufacturing expansion — Amgen's $1B Holly Springs buildout and J&J's $2B Wilson County biologics campus — is pulling specialized talent toward the Triangle corridor, widening the competitive radius Asheville-area life sci employers must compete within for regulatory, quality, and manufacturing hires.
Leadership & Talent Implications
Asheville employers aren't just competing with local peers for scarce life sci talent — they're increasingly measured against Triangle-area biomanufacturing wages and the broader state's regulatory/CMC compensation scale, where VP Regulatory Affairs roles run $320K-$580K and Director CMC roles $220K-$520K nationally. With Clinical Research Associate advertised pay up significantly both locally ($78,011) and nationally ($90,956), while Lab Technician pay is falling in both markets, the signal points toward growing bifurcation: premium pay concentrating in credential-heavy, regulatory-adjacent roles while commodity lab functions soften. Organizations should evaluate whether current compensation structures reflect this widening gap, rather than applying flat merit increases across clinical and lab-support tiers alike.
